Detalhe da pesquisa
1.
Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.
Br J Haematol
; 187(3): 347-355, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290569
2.
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
J Clin Oncol
; 38(29): 3377-3387, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730183
3.
Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study.
Clin Pharmacol Ther
; 105(6): 1456-1461, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570132
4.
Improving the identification of frail elderly newly diagnosed multiple myeloma patients.
Leukemia
; 35(9): 2715-2719, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589752
5.
[Fatal pulmonary tumour embolism as initial manifestation of an occult coecum tumour]. / Fatale pulmonale tumorembolie als eerste manifestatie van een occulte coecumtumor.
Ned Tijdschr Geneeskd
; 153: A227, 2009.
Artigo
em Holandês
| MEDLINE | ID: mdl-19785837